{
    "clinical_study": {
        "@rank": "31854", 
        "arm_group": {
            "arm_group_label": "Vitamin D", 
            "arm_group_type": "Experimental", 
            "description": "Cholecalciferol 300,000 twice"
        }, 
        "brief_summary": {
            "textblock": "Vitamin D deficiency is common in CKD and assciated with CV complications. Endothelial\n      dysfucntion is common in CKD and is a harbinger of atherosclerosis. The study investigated\n      the impact of Vitamin D on endothelial fucntion and blood biomarkers in CKD."
        }, 
        "brief_title": "Impact of Vitamin D on Endothelial Function and Blood Biomarkers Including CD28 Null Cells in CKD", 
        "completion_date": {
            "#text": "June 2013", 
            "@type": "Actual"
        }, 
        "condition": "CKd Patients With Stage 3 and 4", 
        "condition_browse": {
            "mesh_term": "Renal Insufficiency, Chronic"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  CKD 3-4 Age 18-80\n\n        Exclusion Criteria:\n\n          -  Recent MI, CVA, malignancy active infection active inflammation High calcium already\n             on Viatmin D therapy"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "80 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "36", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "December 3, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02005718", 
            "org_study_id": "090129"
        }, 
        "intervention": {
            "arm_group_label": "Vitamin D", 
            "intervention_name": "Cholecalciferol", 
            "intervention_type": "Drug"
        }, 
        "intervention_browse": {
            "mesh_term": [
                "Cholecalciferol", 
                "Vitamin D", 
                "Vitamins"
            ]
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "December 3, 2013", 
        "number_of_arms": "1", 
        "official_title": "Impact of Cholecalciferol on Endothelial Fucntion and Blood Biomarkers in Patients With Chronic Kidney Disease", 
        "overall_official": {
            "affiliation": "St Georges", 
            "last_name": "Debasish Banerjee", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "United Kingdom: Research Ethics Committee", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 3", 
        "primary_completion_date": {
            "#text": "June 2013", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "measure": "Flow mediated dilation", 
            "safety_issue": "No", 
            "time_frame": "16 weeks"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02005718"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "measure": "CD28 null cell frequency", 
                "safety_issue": "No", 
                "time_frame": "16 weeks"
            }, 
            {
                "measure": "Blood biomarkers of endothelial function and inflammation", 
                "safety_issue": "No", 
                "time_frame": "16 weeks"
            }
        ], 
        "source": "St George's, University of London", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "St George's, University of London", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "June 2010", 
        "study_design": "Allocation: Non-Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "December 2013"
    }
}